---
title: "CONBA: Throat lozenges have obtained a drug registration certificate"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/241980565.md"
description: "According to the Zhitong Finance APP, CONBA announced that the company has received the Drug Registration Certificate for the throat lozenge approved and issued by the National Medical Products Administration (referred to as \"NMPA\"). The throat lozenge is an improvement on the already marketed throat mixture. The functions and indications of the throat lozenge include nourishing yin, clearing the throat, and detoxifying, used for treating acute pharyngitis classified as lung heat and yin deficiency syndrome in traditional Chinese medicine, characterized by throat pain (pain during swallowing), dry and burning throat, red tongue, thin coating, and thin pulse"
datetime: "2025-05-27T09:54:04.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/241980565.md)
  - [en](https://longbridge.com/en/news/241980565.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/241980565.md)
generator: "portal-rs"
---

# CONBA: Throat lozenges have obtained a drug registration certificate

According to the Zhitong Finance APP, CONBA (600572.SH) announced that the company has received the Drug Registration Certificate for the throat lozenge approved and issued by the National Medical Products Administration (referred to as "NMPA"). The throat lozenge is an improvement on the already marketed throat mixture. The functions and indications of the throat lozenge include nourishing yin, clearing the throat, and detoxifying, used for treating acute pharyngitis classified as lung heat and yin deficiency syndrome in traditional Chinese medicine, characterized by throat pain (pain during swallowing), dry and burning throat, red tongue, thin coating, and thin pulse

### Related Stocks

- [600572.CN](https://longbridge.com/en/quote/600572.CN.md)

## Related News & Research

- [REG - AstraZeneca PLC - AstraZeneca completes agreement for Zegfrovy](https://longbridge.com/en/news/297603898.md)
- [Cleo Diagnostics to Commence Analytical Validation of Pre-Surgical Ovarian Cancer Blood Test](https://longbridge.com/en/news/297848437.md)
- [07:15 ETTranspire Bio to Participate in Upcoming Healthcare Investor Conferences During September](https://longbridge.com/en/news/297775966.md)
- [NeuroThera Labs seeks FDA orphan drug status for adult Tourette treatment SCI-110](https://longbridge.com/en/news/297783543.md)
- [BioVersys says FDA grants Fast Track designation for BV100 antibiotic candidate](https://longbridge.com/en/news/297733781.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**